A detailed history of Foster & Motley Inc transactions in Organon & Co. stock. As of the latest transaction made, Foster & Motley Inc holds 27,007 shares of OGN stock, worth $413,477. This represents 0.03% of its overall portfolio holdings.

Number of Shares
27,007
Previous 28,234 4.35%
Holding current value
$413,477
Previous $584,000 11.47%
% of portfolio
0.03%
Previous 0.04%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$18.65 - $23.03 $22,883 - $28,257
-1,227 Reduced 4.35%
27,007 $517,000
Q2 2024

Aug 02, 2024

SELL
$17.45 - $21.96 $19,561 - $24,617
-1,121 Reduced 3.82%
28,234 $584,000
Q1 2024

Apr 18, 2024

SELL
$13.78 - $18.8 $51,757 - $70,612
-3,756 Reduced 11.34%
29,355 $552,000
Q4 2023

Feb 01, 2024

SELL
$10.95 - $17.32 $42,267 - $66,855
-3,860 Reduced 10.44%
33,111 $477,000
Q3 2023

Oct 24, 2023

SELL
$16.59 - $23.77 $95,143 - $136,320
-5,735 Reduced 13.43%
36,971 $642,000
Q2 2023

Aug 08, 2023

SELL
$19.27 - $24.63 $189,250 - $241,891
-9,821 Reduced 18.7%
42,706 $889,000
Q1 2023

May 09, 2023

BUY
$21.42 - $32.08 $407,622 - $610,482
19,030 Added 56.81%
52,527 $1.24 Million
Q4 2022

Feb 09, 2023

BUY
$23.31 - $28.61 $34,149 - $41,913
1,465 Added 4.57%
33,497 $936,000
Q3 2022

Nov 04, 2022

BUY
$23.4 - $34.25 $383,900 - $561,905
16,406 Added 104.99%
32,032 $750,000
Q2 2022

Aug 09, 2022

BUY
$31.66 - $38.9 $263,252 - $323,453
8,315 Added 113.73%
15,626 $527,000
Q1 2022

Apr 28, 2022

BUY
$30.45 - $39.36 $222,619 - $287,760
7,311 New
7,311 $255,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Foster & Motley Inc Portfolio

Follow Foster & Motley Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster & Motley Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster & Motley Inc with notifications on news.